Related references
Note: Only part of the references are listed.Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Kjetil Bjornevik et al.
SCIENCE (2022)
The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities
Helen Tremlett et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis
Yin Xu et al.
BRAIN (2021)
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study
Viktor Grut et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
Kjetil Bjornevik et al.
JAMA NEUROLOGY (2020)
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Benedicte Delcoigne et al.
NEUROLOGY (2020)
Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions
Nina L. Fransen et al.
BRAIN (2020)
Prodrome in relapsing-remitting and primary progressive multiple sclerosis
J. M. A. Wijnands et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Michael J. Mina et al.
SCIENCE (2019)
The Immune Epitope Database (IEDB): 2018 update
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2019)
Primary Epstein-Barr virus infection
Samantha K. Dunmire et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells
Asma Hassani et al.
PLOS ONE (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Michael P. Pender et al.
JCI INSIGHT (2018)
Molecular signature of Epstein-Barr virus infection in MS brain lesions
Monica A. Moreno et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sensitivity Analysis in Observational Research: Introducing the E-Value
Tyler J. VanderWeele et al.
ANNALS OF INTERNAL MEDICINE (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update
Alberto Ascherio et al.
SEMINARS IN NEUROLOGY (2016)
Prospective studies of infectious mononucleosis in university students
Jennifer M. Grimm et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA
Kevin Messacar et al.
LANCET (2015)
A Brief Description of the Operation of the DoD Serum Repository
Christopher L. Perdue et al.
MILITARY MEDICINE (2015)
Comprehensive serological profiling of human populations using a synthetic human virome
George J. Xu et al.
SCIENCE (2015)
Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Seroprevalence of Epstein-Barr Virus Infection in US Children Ages 6-19, 2003-2010
Jennifer Beam Dowd et al.
PLOS ONE (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
Hans Lassmann et al.
BRAIN (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Autoantigen discovery with a synthetic human peptidome
H. Benjamin Larman et al.
NATURE BIOTECHNOLOGY (2011)
Primary Infection with the Epstein-Barr Virus and Risk of Multiple Sclerosis
Lynn I. Levin et al.
ANNALS OF NEUROLOGY (2010)
Negative Controls A Tool for Detecting Confounding and Bias in Observational Studies
Marc Lipsitch et al.
EPIDEMIOLOGY (2010)
Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III
J. B. Dowd et al.
EPIDEMIOLOGY AND INFECTION (2009)
What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research
Mirjam J. Knol et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Multiple sclerosis after infectious mononucleosis
Trine Rasmussen Nielsen et al.
ARCHIVES OF NEUROLOGY (2007)
A cohort study among University students: Identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis
DH Crawford et al.
CLINICAL INFECTIOUS DISEASES (2006)
Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
Gerald N. DeLorenze et al.
ARCHIVES OF NEUROLOGY (2006)
Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis
EL Thacker et al.
ANNALS OF NEUROLOGY (2006)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
